Patient Engagement

New drug delivery mechanisms and devices are an opportunity to build relationship with the ultimate customer: the patient.

In the world of patient education, processes, policies, and oversight differ vastly. There is no overarching governance structure. There isn't an accreditation process for educational interventions or patient advocacy organizations that develop the education.

Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter.

Brad Sitler looks at the challenge for pharma of engaging patients and helping physicians provide them with the right information at the right time.

Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. Patient voices are increasing in volume, along with their roles in treatment decisions.

Sarah Krug asks if it is time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust.

How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?

Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma - but is it? Pharm Exec convenes an expert round table to examine how best to make progress and agree on some practical steps for incorporation in the campaign agenda.

The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.

A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health

To decide on a course of treatment, patients need to be told the truth straight up

The simpler the explanation of a disorder and its treatment, the better able a patient is to take proper care of himself

When neither attitudes nor personality drive behavior, Pharma must look to social norms to understand consumer adherence issues